The partnership has been approved by the University of Texas Board of Regents and the Texas Children’s Board of Trustees, according to a Feb. 19 news release from MD Anderson.
Patient care and operations are expected to launch in early 2026, including the creation of new facilities, with more specific information forthcoming.
Together, the organizations aim to expand and improve pediatric cancer clinical trials, cancer treatment innovation and availability, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
